Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890003 · ClinicalTrials.gov registry record · NA
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes
A NA study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03890003 is a NA study that has completed, run by Eli Lilly and Company. The registered enrollment target is 10 participants.
The verdict
NCT03890003, a NA study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this early feasibility study is to assess the predictive low glucose suspend (PLGS) feature's safety, functionality and performance.
Interventions
- DEVICE AID System
- DRUG Insulin Lispro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-03-28 |
| Est. Completion | 2019-05-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03890003
The ClinicalTrials.gov registry entry for NCT03890003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AID System is the first listed.
NCT03890003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03890003 about?
NCT03890003 is a clinical study titled "A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes". The purpose of this early feasibility study is to assess the predictive low glucose suspend (PLGS) feature's safety, functionality and performance.
What is the current status of trial NCT03890003?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-03-28. Estimated completion is 2019-05-06.
What interventions are being tested in trial NCT03890003?
The interventions under investigation include: AID System (DEVICE), Insulin Lispro (DRUG).
Who is sponsoring clinical trial NCT03890003?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.